Highlights and Quick Summary
- EPS (Diluted) for the quarter ending September 30, 2023 was -0.55 (a 17.02% increase compared to previous quarter)
- Year-over-year quarterly EPS (Diluted) increased by 30.95%
- Annual EPS (Diluted) for 2022 was -1.46 (a -23.96% decrease from previous year)
- Annual EPS (Diluted) for 2021 was -1.92 (a 3740.0% increase from previous year)
- Annual EPS (Diluted) for 2020 was -0.05 (a 66.67% increase from previous year)
Visit stockrow.com/PRME
for comprehensive keystats, realtime prices, income statement, balance sheet, cash flow
statement with 10 years of data, and state-of-the-art screener.
Historical EPS (Diluted) of Prime Medicine, Inc.
Most recent EPS (Diluted)of PRME including historical data for past 10 years.Interactive Chart of EPS (Diluted) of Prime Medicine, Inc.
Prime Medicine, Inc. EPS (Diluted) for the past 10 Years (both Annual and Quarterly)
| Year | Q1 | Q2 | Q3 | Q4 | Fiscal Year |
|---|---|---|---|---|---|
| 2023 | -0.55 | -0.47 | -0.44 | – | – |
| 2022 | – | – | -0.42 | -0.37 | -1.46 |
| 2021 | – | – | – | – | -1.92 |
| 2020 | – | – | – | – | -0.05 |
| 2019 | – | – | – | – | -0.03 |
Business Profile of Prime Medicine, Inc.
Sector: Healthcare
Industry: Biotechnology